Back to Search
EILEEN HARRIGAN, MD
MD
Neurology Physician
NPI: 1477059194IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
307766(NY)
Hospice and Palliative Medicine (Psychiatry & Neurology) Physician
Psychiatry & Neurology — Hospice and Palliative Medicine
Code: 2084H0002X
307766(NY)
Education
OTHER
Class of 2018
Research & Publications (7)
The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.
PMID 15101564·Int Clin Psychopharmacol·2004
3-trial
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
PMID 14709949·J Clin Psychopharmacol·2004
3-trial
Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc.
PMID 12031739·Am J Cardiol·2002
4-observational
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
PMID 11401000·Psychopharmacology (Berl)·2001
3-trial
Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate.
PMID 11311931·Psychiatry Res·2001
8-other
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
PMID 11235922·J Clin Psychiatry·2001
3-trial
Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.
PMID 11199944·J Clin Psychopharmacol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 222 E 41ST ST
NEW YORK, NY 10017 - Phone
- (212) 263-7744
Quick Facts
- NPI
- 1477059194
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 8
- Publications
- 7
Are you this provider?
Claim Your Profile